Dimensional Fund Advisors LP Purchases 86,204 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Dimensional Fund Advisors LP boosted its position in Bath & Body Works, Inc. (NYSE:BBWI) by 7.1% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 1,303,487 shares of the company’s stock after acquiring an additional 86,204 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Bath & Body Works were worth $50,901,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently bought and sold shares of BBWI. Envestnet Portfolio Solutions Inc. boosted its position in shares of Bath & Body Works by 5.2% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 5,571 shares of the company’s stock valued at $279,000 after acquiring an additional 277 shares during the period. Empirical Finance LLC raised its holdings in shares of Bath & Body Works by 3.6% in the 1st quarter. Empirical Finance LLC now owns 8,097 shares of the company’s stock worth $405,000 after buying an additional 278 shares in the last quarter. CWM LLC lifted its position in shares of Bath & Body Works by 6.6% during the 2nd quarter. CWM LLC now owns 5,072 shares of the company’s stock worth $198,000 after buying an additional 314 shares during the period. Northwest Bank & Trust Co boosted its stake in Bath & Body Works by 2.5% in the 1st quarter. Northwest Bank & Trust Co now owns 13,094 shares of the company’s stock valued at $655,000 after buying an additional 315 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale lifted its holdings in shares of Bath & Body Works by 1.0% during the first quarter. DekaBank Deutsche Girozentrale now owns 31,797 shares of the company’s stock valued at $1,560,000 after acquiring an additional 322 shares during the period. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Performance

Bath & Body Works stock opened at $32.39 on Monday. The stock has a 50-day simple moving average of $31.85 and a 200 day simple moving average of $40.24. The stock has a market capitalization of $7.23 billion, a P/E ratio of 8.35, a PEG ratio of 0.96 and a beta of 1.77. Bath & Body Works, Inc. has a 52 week low of $26.20 and a 52 week high of $52.99.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.02. The firm had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.54 billion. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. Research analysts forecast that Bath & Body Works, Inc. will post 3.18 earnings per share for the current year.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 6th. Stockholders of record on Friday, August 23rd were issued a dividend of $0.20 per share. The ex-dividend date was Friday, August 23rd. This represents a $0.80 annualized dividend and a dividend yield of 2.47%. Bath & Body Works’s dividend payout ratio is presently 20.62%.

Analyst Upgrades and Downgrades

BBWI has been the subject of a number of research reports. UBS Group lowered their target price on Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating for the company in a research note on Thursday, August 29th. JPMorgan Chase & Co. dropped their price objective on Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating for the company in a report on Thursday, August 29th. Wells Fargo & Company lowered their price target on Bath & Body Works from $48.00 to $40.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Bath & Body Works from $57.00 to $54.00 and set a “buy” rating on the stock in a report on Monday, August 26th. Finally, Morgan Stanley dropped their price objective on shares of Bath & Body Works from $56.00 to $51.00 and set an “overweight” rating on the stock in a report on Thursday, September 5th. Eight equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $42.35.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.